Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer

INTRODUCTION: The initial treatment for high-risk non-muscle invasive bladder cancer (NMIBC) is endoscopic resection of the tumour followed by BCG therapy. In those who develop recurrence, the standard treatment is radical cystectomy. Despite the advancement in surgical technique and postoperative c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamil, Marcus L, Deebajah, Mustafa, Sood, Akshay, Robinson, Kathy, Rao, Krishna, Sana, Sherjeel, Alanee, Shaheen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661574/
https://www.ncbi.nlm.nih.gov/pubmed/31320352
http://dx.doi.org/10.1136/bmjopen-2018-028287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661574/
https://www.ncbi.nlm.nih.gov/pubmed/31320352
http://dx.doi.org/10.1136/bmjopen-2018-028287

Ejemplares similares